Apretude ER 600 MG/3 ML vial 3ML
Ended Awarded
- Contract number
- SPE2DB26FQ77N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,389
Award facts
- Contract value 100% obligated
- $2,388.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,388.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Apretude ER 600 mg/3 ml vials. The contract, which is non-set-aside and competitively awarded, is scheduled for completion by November 19, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical procurement requirements through its diverse portfolio of delivery orders involving brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects the company's established position as a primary supplier within the DLA's pharmaceutical procurement framework and its ability to meet stringent federal medical supply standards through competitive contracting.
Quick answers
Who was awarded contract SPE2DB26FQ77N?
SPE2DB26FQ77N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FQ77N worth?
The government has obligated $2,389 on SPE2DB26FQ77N.
Is contract SPE2DB26FQ77N an order under another contract?
Yes. SPE2DB26FQ77N is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ77N competed?
The extent of competition for SPE2DB26FQ77N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award